MEREO BIOPHARMA GROUP PLC's ticker is MREO and the CUSIP is 589492107. A total of 56 filers reported holding MEREO BIOPHARMA GROUP PLC in Q2 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.1%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,610,537 | -0.2% | 2,023,672 | +2.1% | 0.00% | 0.0% |
Q2 2023 | $2,616,776 | +63.6% | 1,982,406 | -12.4% | 0.00% | – |
Q1 2023 | $1,599,563 | -7.1% | 2,262,785 | -1.4% | 0.00% | – |
Q4 2022 | $1,721,075 | +181.7% | 2,294,766 | +223.6% | 0.00% | – |
Q3 2022 | $611,000 | -24.0% | 709,126 | -1.2% | 0.00% | – |
Q2 2022 | $804,000 | +0.4% | 717,455 | +0.3% | 0.00% | – |
Q1 2022 | $801,000 | -29.7% | 715,185 | +0.4% | 0.00% | – |
Q4 2021 | $1,140,000 | – | 712,363 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Tejara Capital Ltd | 2,188,606 | $1,641,455 | 0.95% |
Monaco Asset Management SAM | 2,049,661 | $1,537,246 | 0.46% |
Rubric Capital Management LP | 10,366,120 | $7,774,590 | 0.34% |
Clearline Capital LP | 2,052,709 | $1,539,532 | 0.28% |
DAFNA Capital Management LLC | 1,096,513 | $822,385 | 0.23% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 7,364,438 | $5,523,329 | 0.23% |
Orbimed Advisors | 10,605,522 | $7,954,142 | 0.15% |
Octagon Capital Advisors LP | 1,000,000 | $750,000 | 0.12% |
Rock Springs Capital Management LP | 6,244,897 | $4,683,673 | 0.11% |
Privium Fund Management (UK) Ltd | 177,200 | $132,900 | 0.10% |